SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-007298
Filing Date
2017-04-26
Accepted
2017-04-26 16:31:07
Documents
42
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mnov-10q_20170331.htm 10-Q 601241
2 EX-31.1 mnov-ex311_9.htm EX-31.1 10997
3 EX-31.2 mnov-ex312_6.htm EX-31.2 10902
4 EX-32.1 mnov-ex321_7.htm EX-32.1 7874
5 EX-32.2 mnov-ex322_8.htm EX-32.2 7803
  Complete submission text file 0001564590-17-007298.txt   2206479

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mnov-20170331.xml EX-101.INS 287837
7 XBRL TAXONOMY EXTENSION SCHEMA mnov-20170331.xsd EX-101.SCH 23458
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnov-20170331_cal.xml EX-101.CAL 23546
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnov-20170331_def.xml EX-101.DEF 74339
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20170331_lab.xml EX-101.LAB 201025
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20170331_pre.xml EX-101.PRE 150931
Mailing Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33185 | Film No.: 17784807
SIC: 2834 Pharmaceutical Preparations